Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,361 to 1,380 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Validation of the functions and prognostic values of synapse-associated proteins in lower-grade glioma. | Biosci Rep | 2021 | 33969375 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| The Emerging Role of B Cells in the Pathogenesis of NAFLD. | Hepatology | 2021 | 33961302 | PubTator, text mining | PubMed |
| Search for Genetic Predictors of Adult Autoimmune Polyendocrine Syndrome in Monozygotic Twins. | Clin Med Insights Endocrinol Diabetes | 2021 | 33953634 | PubTator, text mining | PubMed |
| Targeting cancer homing into the lymph node with a novel anti-CCR7 therapeutic antibody: the paradigm of CLL. | MAbs | 2021 | 33944659 | PubTator, text mining | PubMed |
| Extensive weight loss reduces glycan age by altering IgG N-glycosylation. | Int J Obes (Lond) | 2021 | 33941843 | PubTator, text mining | PubMed |
| The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases. | Front Immunol | 2021 | 33936097 | PubTator, text mining | PubMed |
| Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials. | EBioMedicine | 2021 | 33933782 | PubTator, text mining | PubMed |
| Optimization of therapeutic antibodies. | Antib Ther | 2021 | 33928235 | PubTator, text mining | PubMed |
| Microglia Specific Drug Targeting Using Natural Products for the Regulation of Redox Imbalance in Neurodegeneration. | Front Pharmacol | 2021 | 33927630 | PubTator, text mining | PubMed |
| Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer's disease: from current to future challenges. | J Nanobiotechnology | 2021 | 33926475 | PubTator, text mining | PubMed |
| Dendritic Cell Tumor Vaccination via Fc Gamma Receptor Targeting: Lessons Learned from Pre-Clinical and Translational Studies. | Vaccines (Basel) | 2021 | 33924183 | PubTator, text mining | PubMed |
| Lipopolysaccharide-Enhanced Responses against Aryl Hydrocarbon Receptor in FcgRIIb-Deficient Macrophages, a Profound Impact of an Environmental Toxin on a Lupus-Like Mouse Model. | Int J Mol Sci | 2021 | 33919603 | PubTator, text mining | PubMed |
| An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia. | Cancers (Basel) | 2021 | 33915811 | PubTator, text mining | PubMed |
| A Novel Image Analysis Approach Reveals a Role for Complement Receptors 1 and 2 in Follicular Dendritic Cell Organization in Germinal Centers. | Front Immunol | 2021 | 33912182 | PubTator, text mining | PubMed |
| Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19. | Front Immunol | 2021 | 33912161 | PubTator, text mining | PubMed |
| New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine. | Expert Opin Investig Drugs | 2021 | 33909517 | PubTator, text mining | PubMed |
| Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules. | BMC Endocr Disord | 2021 | 33902539 | PubTator, text mining | PubMed |
| Regulatory T cells induce polarization of pro-repair macrophages by secreting sFGL2 into the endometriotic milieu. | Commun Biol | 2021 | 33893391 | PubTator, text mining | PubMed |
| Single-cell multi-omics analysis of the immune response in COVID-19. | Nat Med | 2021 | 33879890 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=69